Related Experiment Videos

Predicting tissue outcome in stroke: new approaches

Leif Ostergaard1, Kristjana Yr Jónsdóttir, Kim Mouridsen

  • 1Center of Functionally Integrative Neuroscience, Department of Neuroradiology, University of Aarhus, Aarhus University Hospital, Aarhus, Denmark. leif@cfin.dk

Abstract

Insights

Advanced MRI techniques can identify tissue at risk for stroke, improving treatment targeting beyond the standard time window. These methods estimate individual infarct risk, aiding in the development of new stroke therapies.

Area of Science:

  • Neuroimaging
  • Stroke Research
  • Medical Informatics

Background:

  • Multimodal MRI is crucial for understanding acute stroke and guiding therapy.
  • The perfusion-diffusion mismatch is a key target for extended stroke treatment windows.
  • Infarct risk is highly variable within the diffusion and perfusion lesion.

Purpose of the Study:

  • To review techniques for accurately imaging and modeling penumbral infarct risk.
  • To explore advanced MRI methods for assessing tissue at risk in acute stroke.
  • To discuss the role of predictive models in stroke therapy.

Main Methods:

  • Utilizing blood oxygen level-dependent contrast MRI to assess oxygen supply.
  • Employing models of oxygen delivery capacity to detect tissue-at-risk.
  • Integrating multimodal and follow-up MRI data using informatics approaches for infarct progression modeling.

Main Results:

  • Oxygen supply assessment methods improve the detection of tissue-at-risk.
  • Informatics approaches applied to acute imaging data can assign infarct risks to mismatch tissue.
  • Estimates of tissue infarct risk have shown potential in detecting treatment-related risk reduction.

Conclusions:

  • MRI methods can detect metabolic derangements in ischemia, identifying penumbral tissue.
  • Predictive models enhance the perfusion-diffusion mismatch concept with voxel-based risk estimates.
  • Future predictive models may offer advanced prognostic support and facilitate cost-effective stroke therapy testing.